Key result
Aortic valve replacement with the Perceval S bioprosthesis in moderate-high-risk patients resulted in an observed mortality of 4.4% and a 1-year survival rate of 98%.
Population
448 moderate-high-risk patients undergoing aortic valve replacement in Spain, mean age 79.24, 61.2% women…
Design
Cohort
Follow-up
mean 12 ± 3 months
Authors
Loading...
May support sutureless AVR in moderate-high-risk patients; leaves open need for randomized comparisons.
Cohort (n=448)
Yes
The Perceval S sutureless bioprosthesis demonstrated low mortality and morbidity with good haemodynamic results in moderate-to-high-risk patients undergoing aortic valve replacement.
García et al. (2017) conducted a cohort in Moderate-high-risk aortic surgery (n=448). Perceval S bioprosthesis was evaluated on Observed mortality. Aortic valve replacement with the Perceval S bioprosthesis in moderate-high-risk patients resulted in an observed mortality of 4.4% and a 1-year survival rate of 98%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: